Matches in Nanopublications for { <http://bio2rdf.org/drugbank:DB05093> ?p ?o ?g. }
Showing items 1 to 12 of
12
with 100 items per page.
- drugbank:DB05093 type drugbank_vocabulary:Drug assertion.
- drugbank:DB05093 label "AX200 [drugbank:DB05093]" assertion.
- drugbank:DB05093 seeAlso DB05093 assertion.
- drugbank:DB05093 description "AX200, which has been developed for the treatment of stroke, is the most advanced drug candidate and is halfway through the process of gaining clinical approval. The expression of the endogenous AX200 protein in the brain is increased after brain damage. Thus, if this drug administered in the acute phase of stroke, the brainâs own protective action is supported. And this is where the double neurotherapeutic approach is most beneficial: AX200 stops neuronal cell death in the acute phase of stroke, while stimulating simultaneously the regeneration of nervous tissue through the induction of neuro- and arteriogenesis and supporting the reorganisation of the nervous system." assertion.
- drugbank:DB05093 identifier "drugbank:DB05093" assertion.
- drugbank:DB05093 title "AX200" assertion.
- drugbank:DB05093 drugbank_vocabulary:x-cas cas: assertion.
- drugbank:DB05093 drugbank_vocabulary:drugbank-id "DB05093" assertion.
- drugbank:DB05093 bio2rdf_vocabulary:x-identifiers.org DB05093 assertion.
- drugbank:DB05093 bio2rdf_vocabulary:uri "http://bio2rdf.org/drugbank:DB05093" assertion.
- drugbank:DB05093 bio2rdf_vocabulary:namespace "drugbank" assertion.
- drugbank:DB05093 bio2rdf_vocabulary:identifier "DB05093" assertion.